Fibroblast Growth Factor 4 Transfection of MCF-7 Cells Produces Cell Lines That Are Tumorigenic and Metastatic in Ovariectomized or Tamoxifen-treated Athymic Nude Mice

Cancer Research

Volumn 53, Issue 9, 1993, Pages 2168-2177

  Honig, Susan F ^a,b,b   Kurebayashi, Junichi ^a   Zwiebel, James ^a,b   Lippman, Marc E ^a,b   Dickson, Robert B ^a,b   Kern, Francis G ^a,b  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; CHROMOGENIC SUBSTRATE; ESTROGEN; FIBROBLAST GROWTH FACTOR; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENICITY; CELL GROWTH; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; NUDE MOUSE; OVARIECTOMY; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMAL; BREAST NEOPLASMS; CELL DIVISION; ESTROGENS; FEMALE; FIBROBLAST GROWTH FACTORS; HUMAN; IN VITRO; MICE; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OVARIECTOMY; PROTO-ONCOGENE PROTEINS; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0027230694     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Dickson, R. B. McManaway, M. E. and Lippman, M. E. Estrogen-induced factors of breast cancer cells partially replace estrogen to promote tumor growth. Science (Washington DC), 232: 1540-1543, 1986.
2. Baird, A. and Klagsbrun, M. The fibroblast growth factor family. Cancer Cells (Cold Spring Harbor), 3: 239-251, 1991.
3. Dickson, C. Smith, R. Brookes, S. and Peters, G. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell, 37: 529-536, 1984.
4. Murakami, A. Tanaka, H. and Matsuzawa, A. Association of hst gene expression with metastatic phenotype in mouse mammary tumors. Cell Growth Differ. 1: 225-231, 1990.
5. Wellstein, A. Lupu, R. Zugmaier, G. Flamm, S. L. Cheville, A. L. Delli Bovi, P. Basilico, C. Lippman, M. E. and Kem, F. G. Autocrine growth stimulation by secreted K-FGF but not by endogenous basic FGF. Cell Growth Differ. 1: 1-5, 1990.
6. Wellstein, A. Zugmaier, G. Califano, J. A. Kern, F. Paik, S. and Lippman, M. E. Tumor growth dependent on Kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate. J. Natl. Cancer Inst. 83: 716-720, 1991.
7. Weidner, N. Semple, J. P. Welch, W. R. and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324: 1-8, 1991.
8. Harris, A. L. Horak, E. Leek, R. Bicknell, R. Relf, M. Smith, K. Greenall, M. Kuzu, I. and Garter, K. C. Quantitative angiogenesis in human breast cancer-correlation with lymph node metastasis and assessment of vascular growth factors. Proc. Am. Assoc. Cancer Res. 33: 75, 1992.
9. Kurebayashi, J. McLeskey, S. W. Johnson, M. D. Lippman, M. E. Dickson, R. B. and Kern, F. G. Quantitative demonstration of spontaneous metastasis by MCF-7 human breast cancer cells cotransfected with fibroblast growth factor 4 and lacZ. Cancer Res. 53: 2178-2187, 1993.
10. Chen, C. and Okayama, H. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol, 7: 2745-2752, 1987.
11. Krawczyk, Z. and Wu, C. Isolation of RNA for dot hybridization by heparin-DNase I treatment of whole cell lysate. Anal. Biochem. 165: 20-27, 1987.
12. Sambrook, J. Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
13. Brünner, N. Thompson, E. W. Spang-Thomsen, M. Rygaard, J. Dano, K. and Zwiebel, J. A. lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis. Eur. J. Cancer, 28A: 1989-1995, 1992.
14. Osborne, C. K. Hobbs, K. and Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res. 45: 584-590, 1991.
15. Boven, E. and Winograd, B. The Nude Mouse in Oncology Research. Boca Raton, FL: CRC Press, 1992.
16. Price, J. E. Polyzos, A. Zhang, R. D. and Daniels, L. M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50: 717-721, 1990.
17. Ozzello, L. and Sordat, M. Behavior of tumors produced by transplantation of human mammary cell lines in athymic nude mice. Eur. J. Cancer, 16: 553-559, 1980.
18. Shafie, S. M. and Liotta, L. A. Formation of metastasis by human breast carcinoma cells (MCF-7) in nude mice. Cancer Lett. II: 81-87, 1980.
19. H-transfected MCF-7 cells. Int. J. Cancer, 50: 665-669, 1992.
20. Knabbe, C. Lippman, M. E. Wakefield, L. M. Flanders, K. C. Kasid, A. Derynck, R. and Dickson, R. B. Evidence that transforming growth factor β is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
21. Clarke, R. Brünner, N. Katz, D. Glanz, P. Dickson, R. B. Lippman, M. E. and Kern, F. G. The effects of a constitutive expression of transforming growth factor a on the growth of MCF-7 human breast cancer cells in vitro and in vivo. Mol. Endocrinol. 3: 372-380, 1989.
22. Daly, R. J. Harris, W. H. Wang, D. Y. and Darbre, P. D. Autocrine production of insulin-like growth factor II using an inducible expression system results in reduced estrogen sensitivity of MCF-7 human breast cancer cells. Cell Growth Differ. 2: 457-464, 1991.
23. Cullen, K. J. Lippman, M. E. Chow, D. Hill, S. Rosen, N. and Zweibel, J. A. Insulin-like growth factor overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol. Endocrinol. 6: 91-100, 1992.
24. Van Roy, F. Marcel, M. Vleminckx, K. Beyaert, R. Fiers, W. Devleeschouwer, N. Muquardt, C. Legros, N. Bracke, M. and Leclercq, G. Hormone sensitivity in vitro and in vivo of v-ros-transfected MCF-7 cell derivatives. Int. J. Cancer, 46: 522-532, 1990.
25. Sommers, C. L. Papageorge, A. Wilding, G. and Gelmann, E. P. Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH. Cancer Res. 50: 67-71, 1990.
26. Clarke, R. Brünner, N. Thompson, E. W. Glanz, P. Katz, D. Dickson, R. B. and Lippman, M. E. The inter-relationships between ovarian-independent growth, tum-origcnicity, invasiveness and antioestrogen resistance in the malignant progression of human breast cancer. J. Endocrinol. 122: 331-340, 1989.
27. Clarke, R. Brünner, N. Katzenellenbogen, B. S. Thompson, E. W. Norman, M. J. Koppi, C. Paik, S. Lippman, M. E. and Dickson, R. B. Progression of human breast cancer cells from hormone-dependent to hormone-independent growth both in vitro and in vivo. Proc. Nad. Acad. Sci. USA, 86: 3649-3653, 1989.
28. Katzenellenbogen, B. S. Kendra, K. L. Norman, M. J. and Berthois, Y. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens. Cancer Res. 47: 4355-4360, 1987.
29. Lippman, M. Bolan, G. and Huff, K. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36: 4595-4601, 1976.
30. Murphy, C. S. Pink, J. J. and Jordan, V. C. Characterization of a receptor-negative, hormone-nonresponsive clone derived from a T47D human breast cancer cell line kept under estrogen-free conditions. Cancer Res. 50: 7285-7292, 1990.
31. Welshons, W. V. and Jordan, V. C. Adaptation of estrogen-dependent MCF-7 cells to low estrogen (phenol red-tree) culture. Eur. J. Cancer Clin. Oncol. 23: 1935-1939, 1987.
32. Murphy, C. S. Meisner, L. F. Wu, S. Q. and Jordan, V. C. Short- and long-term estrogen deprivation of T47D human breast cancer cells in culture. Eur. J. Cancer Clin. Oncol. 25: 1777-1788, 1989.
33. Gottardis, M. M. and Jordan, V. C. Development of tamoxifen-stimulated growth of MCF-7 tumors in athymic mice after long-term antiestrogen administration. Cancer Res. 48: 5183-5187, 1988.
34. Jordan, V. C. Molecular and cellular basis for the use of tamoxifen as chemopreven-tion. Proc. Am. Assoc. Cancer Res. 33: 566-567, 1992.
35. Kandel, J. Bossy-Wetzel, E. Radvanyi, F. Klagsbrun, M. Folkman, J. and Hanahan, D. Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell, 66: 1095-1104, 1991.
36. Takahashi, K. Suzuki, K. Kawahara, S. and Ono, T. Growth stimulation of human breast epithelial cells by basic fibroblast growth factor in serum-free medium. Int. J. Cancer, 43: 870-874, 1989.
37. Briozzo, P. Badet, J. Capony, F. Pieri, I. Montcourrier, P. Barritault, D. and Rochefort, H. MCF7 mammary cancer cells respond to bFGF and internalize it following its release from extracellular matrix: a permissive role of cathepsin D. Exp. Cell Res. 194: 252-259, 1991.
38. Bronzert, D. A. Triche, T. J. Gleason, P. and Lippman, M. E. Isolation and characterization of an estrogen-inhibited variant derived from the MCF-7 breast cancer cell line. Cancer Res. 44: 3942-3951, 1984.
39. Gottardis, M. M. Jiang, S. Y. Jeng, M. H. and Jordan, V. C. Inhibition of tamoxifen-stimulated growth of an MCF-7 tumor variant in athymic mice by novel steroidal antiestrogens. Cancer Res. 49: 4090-4093, 1989.
40. Flamm, S. L. Wellstein, A. Lupu, R. Kem, F. Lippman, M. E. and Gelmann, E. P. Expression of fibroblast growth factor peptides in normal and malignant human mammary epithelial cells. Proc. Am. Assoc. Cancer Res. 30: 71, 1989.
41. Strohmeyer, T. Peter, S. Hartmann, M. Munemitsu, S. Ackermann, R. Ullrich, A. and Slamon, D. Expression of the hst-1 and c-kit protooncogenes in human testicular germ cell tumors. Cancer Res, 51: 1811-1816, 1991.
42. Schofield, P. N. Ekstrom, T. J. Granerus, M. and Engstrom, W. Differentiation associated modulation of K-FGF expression in a human teratocarcinoma cell line and in primary germ cell tumours. FEBS Lett. 280: 8-10, 1991.
43. Liscia, D. S. Merlo, G. R. Garrett, C. French, D. Mariani-Costantini, R. and Callahan, R. Expression of int-2 mRNA in human tumors amplified at the int-2 locus. Oncogene, 4: 1219-1224, 1989.
44. Theillet, C. Le Roy, X. De Lapeyriere, O. Grosgeorges, J. Adnane, J. Raynaud, S. D. Simony-Lafontaine, J. Goldfarb, M. Escot, C. Birnbaum, D. and Gaudray, P. Amplification of FCF-related genes in human tumors: possible involvement of hst in breast carcinomas. Oncogene, 4: 915-922, 1989.
45. Li, S. and Shipley, G. D. Expression of multiple species of basic fibroblast growth factor mRNA and protein in normal and tumor-derived mammary epithelial cells in culture. Cell Growth Differ. 2: 195-202, 1991.
46. Theillet, C. Adnane, J. Szepetowski, P. Simon, M. P., Jeanteur, P. Birnbaum, D. and Gaudray, P. BCL-1 participates in the Uql3 amplification found in breast cancer. Oncogene, 5: 147-149, 1990.
47. Fantl, V. Richards, M. A. Smith, R. Lammie, G. A. Johnstone, G. Allen, D. Gregory, W. Peters, G. Dickson, C. and Barnes, D. M. Gene amplification on chromosome band 11ql3 and oestrogen receptor status in breast cancer. Eur. J. Cancer, 26: 423-429, 1990.
48. Ding, I. Y. F. McLeskey, S. W. Chang, K. Fu, Y. M. Acol, J. C. Shon, M. T. Alitalo, K. and Kern, F. G. Expression of fibroblast growth factors (FGFs) and receptors (FGFRs) in human breast carcinomas. Proc. Am. Assoc. Cancer Res. 33: 269, 1992.
49. Burgess, W. H. and Maciag, T. The heparin-binding (fibroblast) growth factor family of proteins. Annu. Rev. Biochem. 58: 575-606, 1989.
50. Cordon-Cardo, C. Vlodavsky, I. Haimovitz-Friedman, A. Hicklin, D. and Fuks, Z. Expression of basic fibroblast growth factor in normal human tissues. Lab. Invest. 63: 832-840, 1990.
51. Rifkin, D. B. and Moscatelli, D. Recent developments in the cell biology of basic fibroblast growth factor. J. Cell Biol. 109: 1-6, 1989.
52. Gomm, J. J. Smith, J. Ryall, G. K. Baillie, R. Turnbull, L. and Coombes, R. C. Localization of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res. 57: 4685-4692, 1991.
53. Mignatti, P. and Rifkin, D. Release of basic fibroblast growth factor, an angiogenic factor devoid of secretory signal sequence: a trivial phenomenon or a novel secretion mechanism? J. Cell. Biochem. 47: 201-207, 1991.
54. Muthukrishnan, L. Warder, E. and McNeil, P. L. Basic fibroblast growth factor is efficiently released from a cytosolic storage site through plasma membrane disruptions of endothelial cells. J. Cell. Physiol. 148: 1-16, 1991.
55. Partanen, J. Makela, T. P. Alitalo, R. Lehvaslaiho, H. and Alitalo, K. Putative tyrosine kinases expressed in K-562 human leukemia cells. Proc. Natl. Acad. Sci. USA, 87: 8913-8917, 1990.
56. Mansukhani, A. Moscatelli, D. Talarico, D. Levytska, V. and Basilico, C. A murine fibroblast growth factor (FGF) receptor expressed in CHO cells is activated by basic FGF and Kaposi FGF. Proc. Natl. Acad. Sci. USA, 87: 4378-4382, 1990.
57. Keegan, K. Johnson, D. E. Williams, L. T. and Hayman, M. J. Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc. Natl. Acad. Sci. USA, 88: 1095-1099, 1991.
58. Hou, J. Kan, M. Wang. F. Xu, J. M. Nakahara, M. McBride, G. McKeehan, K. and McKeehan, W. L. Substitution of a putative half-cystine residue in either of the two juxtamembrane immunoglobulin-like loops destroys ligand-binding activity of both three and two loop isoforms of the heparin-binding fibroblast growth factor receptor. J. Biol. Chem. 267: 17804-17808, 1992.
59. Adnane, J. Gaudray, P. Dionne, C. A. Crumley, G. Jaye, M. Schlessinger, J. Jeanteur, P. Birnbaum, D. and Theillet, C. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene, 6: 659-663, 1991.